Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Next Generation Precision Imaging for Cancer Immunotherapy
NCT05805358Phase 2Not yet recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized 13C-pyruvate in gynecologic cancer, sponsored by Chang Gung Memorial Hospital. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
gynecologic cancer
Beyond the preview
Go deeper on NCT05805358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05805358.